Open AccessAssessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates
Author(s) -
Renru Han,
Xuelin Yang,
Yang Yang,
Yan Guo,
Daqiang Yin,
Li Ding,
Wei Shi,
Demei Zhu,
Fupin Hu
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.01092-21
Subject(s) - etest , broth microdilution , klebsiella pneumoniae , ceftazidime/avibactam , microbiology and biotechnology , medicine , minimum inhibitory concentration , antimicrobial , chemistry , biology , escherichia coli , biochemistry , gene
Multidrug-resistant Gram-negative bacteria, especially for extended-spectrum β-lactamases-producing and carbapenemase-producingEnterobacterales , are disseminating rapidly around the world. Treatment options for these infections are limited, which prompt the development of novel or combinational therapies to combat the infections caused by multidrug-resistant pathogens.